x

Contineum Therapeutics, Inc. (Nasdaq:CTNM)

Health Care/Life Sciences • Biotechnology
CIK 1855175
Company

Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company was founded by Daniel S. Lorrain on May 9, 2017 and is headquartered in San Diego, CA.

Address
3565 General Atomics Court
Suite 200
San Diego, California 92121
Employees
31
Stock Info
Close
$6.10
Day Range
5.92 - 6.44
52 Week Range
5.92 - 22.00
Average volume
85.8K
Short Interest
848.41K (02/14/25)
% of Float Shorted
6.32%
Market Cap
$157.24M
Revenue
$50M
Net Income
$22.72M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$1.12
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Director
Todd R. Brady
Director
Lori M. Lyons-Williams
Director
Olivia C. Ware
Independent Director
Troy A. Ignelzi
Independent Director
Sarah Boyce
SEC filings
DateFormEvent
27 Nov, 2024 4
20 Nov, 2024 4
18 Nov, 2024 144
14 Nov, 2024 SC 13G
6 Nov, 2024 8-K
6 Nov, 2024 10-Q
31 Oct, 2024 SCHEDULE 1
14 Aug, 2024 8-K/A
14 Aug, 2024 10-Q
14 Aug, 2024 4
13 Aug, 2024 8-K
24 Jun, 2024 8-K
24 Jun, 2024 3
24 Jun, 2024 4
3 Jun, 2024 3
3 Jun, 2024 4
31 May, 2024 8-K
29 May, 2024 4
29 May, 2024 4
29 May, 2024 4
29 May, 2024 4
29 May, 2024 4
29 May, 2024 4
29 May, 2024 4
29 May, 2024 4
29 May, 2024 4
20 May, 2024 3
20 May, 2024 4
20 May, 2024 8-K
16 May, 2024 10-Q
16 May, 2024 8-K
15 Apr, 2024 SC 13G
15 Apr, 2024 SC 13G
11 Apr, 2024 4
10 Apr, 2024 3
10 Apr, 2024 SC 13G
9 Apr, 2024 S-8
9 Apr, 2024 8-K
8 Apr, 2024 424B4 IPO completed
5 Apr, 2024 SEC STAFF
4 Apr, 2024 3
4 Apr, 2024 3
4 Apr, 2024 3
4 Apr, 2024 3
4 Apr, 2024 3
4 Apr, 2024 3
4 Apr, 2024 3
4 Apr, 2024 3
4 Apr, 2024 EFFECT
4 Apr, 2024 CERT
4 Apr, 2024 3
2 Apr, 2024 CORRESP
2 Apr, 2024 8-A12B
2 Apr, 2024 CORRESP
1 Apr, 2024 S-1/A
21 Mar, 2024 CORRESP
15 Mar, 2024 CORRESP
15 Mar, 2024 S-1
23 Feb, 2024 UPLOAD
15 Feb, 2024 DRSLTR
15 Feb, 2024 DRS/A
7 Feb, 2024 UPLOAD
29 Jan, 2024 DRS/A
29 Jan, 2024 DRSLTR
25 Jan, 2024 SEC STAFF
11 Jan, 2024 UPLOAD
13 Dec, 2023 DRS
Last update:2025-03-06 12:01:20.382050
Contineum Therapeutics, Inc. by TradingView

Sign Up to Subscribe